A 35-year-old woman with a history of chronic rhinosinusitis presents to the emergency department with acute left-sided periorbital edema, proptosis, and ophthalmoplegia that developed over 24 hours. She has fever (38.8°C), chemosis, and a relative afferent pupillary defect (RAPD). CT orbit and paranasal sinuses shows left maxillary and ethmoid sinusitis with obliteration of orbital fat planes. Blood cultures are pending. Which organism is most likely responsible, and what is the most appropriate empiric antibiotic regimen?

Explanation

## Microbiology of Orbital Cellulitis from Sinusitis ### Most Common Organisms **Key Point:** Orbital cellulitis secondary to paranasal sinusitis is typically polymicrobial, involving aerobic and anaerobic bacteria. The source (ethmoid/maxillary sinusitis) guides organism prediction. | Organism | Frequency | Source | Notes | |---|---|---|---| | *Streptococcus pneumoniae* | Most common (30–40%) | Sinusitis, hematogenous | Gram-positive coccus; penicillin-resistant strains common in India | | *Staphylococcus aureus* | Common (20–30%) | Sinusitis, skin flora | MRSA prevalence increasing | | Anaerobes (*Peptostreptococcus*, *Prevotella*, *Bacteroides*) | 20–40% | Sinusitis, dental sources | Polymicrobial infections | | *Haemophilus influenzae* | Less common (5–10%) | Sinusitis | Declining due to Hib vaccination | | *Pseudomonas aeruginosa* | Rare (< 5%) | Immunocompromised, trauma, surgery | Not typical in immunocompetent patients | ### Why *Streptococcus pneumoniae* Is Most Likely - **High-Yield:** In sinusitis-related orbital cellulitis, *S. pneumoniae* is the single most common pathogen in immunocompetent adults. - The patient has chronic rhinosinusitis (predisposing factor) with acute orbital spread. - Gram-positive cocci are the predominant isolates in this setting. ## Empiric Antibiotic Regimen ### Recommended First-Line Therapy **Ceftriaxone 2 g IV 6-hourly + Vancomycin 15–20 mg/kg IV 8-hourly + Metronidazole 500 mg IV 8-hourly** ### Rationale for Each Agent | Agent | Coverage | Rationale | |---|---|---| | **Ceftriaxone** | *S. pneumoniae*, *H. influenzae*, Gram-negatives | Third-generation cephalosporin; good CNS/orbital penetration | | **Vancomycin** | MRSA, penicillin-resistant *S. pneumoniae* | Essential for resistant Gram-positive cocci; high prevalence in India | | **Metronidazole** | Anaerobes (*Peptostreptococcus*, *Prevotella*, *Bacteroides*) | Covers polymicrobial anaerobic component; good orbital penetration | **Clinical Pearl:** This triple-agent regimen covers the full spectrum of sinusitis-derived orbital cellulitis (aerobes + anaerobes) while awaiting culture results. ### Duration - IV antibiotics: **10–14 days minimum** (longer if abscess present). - Transition to oral (e.g., amoxicillin-clavulanate + metronidazole) only after clinical improvement. - Total course: 3–4 weeks. ## Why Other Options Are Incorrect **Warning:** Monotherapy or dual therapy is inadequate for polymicrobial orbital cellulitis from sinusitis. ### Inadequate Regimens - **Piperacillin-tazobactam + ciprofloxacin:** Overkill for *Pseudomonas* coverage (rare in immunocompetent patients); misses anaerobes; fluoroquinolones have poor anaerobic coverage. - **Clindamycin monotherapy:** Covers anaerobes and some Gram-positives, but insufficient coverage of *S. pneumoniae* (especially resistant strains) and Gram-negatives. - **Amoxicillin-clavulanate monotherapy:** Inadequate for resistant *S. pneumoniae*, no vancomycin coverage, and insufficient anaerobic coverage in polymicrobial infections.